|
DUSP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.10689999999847E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65466999999531E-05 |
| Normal-vs-Stage2 |
2.299600E-02 |
| Normal-vs-Stage3 |
1.241420E-01 |
| Normal-vs-Stage4 |
8.285400E-01 |
| Stage1-vs-Stage2 |
8.100400E-01 |
| Stage1-vs-Stage3 |
2.163200E-01 |
| Stage1-vs-Stage4 |
9.305800E-02 |
| Stage2-vs-Stage3 |
4.599800E-01 |
| Stage2-vs-Stage4 |
1.307010E-01 |
| Stage3-vs-Stage4 |
3.932800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67916999999074E-05 |
| Normal-vs-AfricanAmerican |
2.840700E-03 |
| Normal-vs-Asian |
3.690000E-01 |
| Caucasian-vs-AfricanAmerican |
6.956400E-01 |
| Caucasian-vs-Asian |
9.161000E-01 |
| AfricanAmerican-vs-Asian |
8.202400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.212910E-04 |
| Normal-vs-Female |
2.241800E-04 |
| Male-vs-Female |
2.410000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.001600E-02 |
| Normal-vs-Extreme_Weight |
3.030100E-04 |
| Normal-vs-Obese |
4.276200E-03 |
| Normal-vs-Extreme_Obese |
3.603300E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.572000E-01 |
| Normal_Weight-vs-Obese |
8.010200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.564000E-02 |
| Extreme_Weight-vs-Obese |
7.297800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.850190E-02 |
| Obese-vs-Extreme_Obese |
2.211800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.141300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.60089999981616E-07 |
| Normal-vs-Age(61-80Yrs) |
8.281200E-03 |
| Normal-vs-Age(81-100Yrs) |
4.925000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.953000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.728210E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.524400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.904600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.025900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.814000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.02189999964908E-07 |
| Normal-VS-Type2 PRCC |
1.701450E-03 |
| Normal-VS-KIRP CIMP |
4.014000E-01 |
| Normal-VS-Unclassified PRCC |
8.520900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.916400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.781100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.024200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.087900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.632000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.082000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.956900E-03 |
| Normal-vs-N1 |
3.667200E-01 |
| Normal-vs-N2 |
6.931000E-01 |
| N0-vs-N1 |
2.281800E-01 |
| N0-vs-N2 |
2.270600E-01 |
| N1-vs-N2 |
4.117600E-01 |
|
|
